Previous Article | Next Article 
Journal of Clinical Microbiology, October 1999, p. 3175-3178, Vol. 37, No. 10
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Development of a Species-Specific PCR-Restriction
Fragment Length Polymorphism Analysis Procedure for Identification of
Madurella mycetomatis
Abdalla O. A.
Ahmed,1,2
Moawia M.
Mukhtar,1
Marly
Kools-Sijmons,3
Ahmed H.
Fahal,4
Sybren
de
Hoog,5
Bert Gerrits
van den
Ende,5
Eduard E.
Zijlstra,1,
Henri
Verbrugh,3
El Sir A. M.
Abugroun,2
Ahmed M.
Elhassan,1 and
Alex
van Belkum3,*
Institute of Endemic Diseases,1
Faculty of Medical Laboratory Sciences,2
and Department of Surgery,4 University
of Khartoum, Sudan, and Department of Microbiology and
Infectious Diseases, Erasmus University Medical Center Rotterdam
(EMCR), Rotterdam,3 and Centraalbureau
voor Schimmelcultures (CBS), Baarn,5 The
Netherlands
Received 12 May 1999/Returned for modification 10 June
1999/Accepted 8 July 1999
Madurella mycetomatis is the commonest cause of
eumycetoma in Sudan and other countries in tropical Africa. Currently,
the early diagnosis of mycetoma is difficult. In attempting to improve the identification of M. mycetomatis and, consequently, the
diagnosis of mycetoma, we have developed specific oligonucleotide
primers based on the sequence of the internal transcribed spacer (ITS) regions spacing the genes encoding the fungal ribosomal RNAs. The ITS
regions were amplified with universal primers and sequenced, and then
two sets of species-specific primers were designed which specifically
amplify parts of the ITS and the 5.8S ribosomal DNA gene. The new
primers were tested for specificity with DNA isolated from human
mycetoma lesions and DNA extracted from cultures of M. mycetomatis reference strains and related fungi as well as human
DNA. To study the genetic variability of the ITS regions of M. mycetomatis, ITS amplicons were obtained from 25 different clinical isolates and subjected to restriction fragment length polymorphism (RFLP) analysis with CfoI, HaeIII,
MspI, Sau3AI, RsaI, and
SpeI restriction enzymes. RFLP analysis of the ITS region did not reveal even a single difference, indicating the homogeneity of
the isolates analyzed during the current study.
*
Corresponding author. Mailing address: Department of
Medical Microbiology & Infectious Diseases, Erasmus University Medical Center Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Phone: 00-31-10-4635813. Fax: 00-31-10-4633875. E-mail: vanbelkum{at}bacl.azr.nl.
Present address: College of Medicine, Chichiri, Blantyre 3, Malawi.
Journal of Clinical Microbiology, October 1999, p. 3175-3178, Vol. 37, No. 10
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Zeng, X., Kong, F., Halliday, C., Chen, S., Lau, A., Playford, G., Sorrell, T. C.
(2007). Reverse Line Blot Hybridization Assay for Identification of Medically Important Fungi from Culture and Clinical Specimens. J. Clin. Microbiol.
45: 2872-2880
[Abstract]
[Full Text]
-
van de Sande, W. W. J., Fahal, A. H., Riley, T. V., Verbrugh, H., van Belkum, A.
(2007). In vitro susceptibility of Madurella mycetomatis, prime agent of Madura foot, to tea tree oil and artemisinin. J Antimicrob Chemother
59: 553-555
[Abstract]
[Full Text]
-
Desnos-Ollivier, M., Bretagne, S., Dromer, F., Lortholary, O., Dannaoui, E.
(2006). Molecular identification of black-grain mycetoma agents.. J. Clin. Microbiol.
44: 3517-3523
[Abstract]
[Full Text]
-
van de Sande, W. W. J., Janse, D.-J., Hira, V., Goedhart, H., van der Zee, R., Ahmed, A. O. A., Ott, A., Verbrugh, H., van Belkum, A.
(2006). Translationally Controlled Tumor Protein from Madurella mycetomatis, a Marker for Tumorous Mycetoma Progression. J. Immunol.
177: 1997-2005
[Abstract]
[Full Text]
-
van de Sande, W. W. J., Gorkink, R., Simons, G., Ott, A., Ahmed, A. O. A., Verbrugh, H., van Belkum, A.
(2005). Genotyping of Madurella mycetomatis by Selective Amplification of Restriction Fragments (Amplified Fragment Length Polymorphism) and Subtype Correlation with Geographical Origin and Lesion Size. J. Clin. Microbiol.
43: 4349-4356
[Abstract]
[Full Text]
-
van de Sande, W. W. J., Luijendijk, A., Ahmed, A. O. A., Bakker-Woudenberg, I. A. J. M., van Belkum, A.
(2005). Testing of the In Vitro Susceptibilities of Madurella mycetomatis to Six Antifungal Agents by Using the Sensititre System in Comparison with a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5-Sulfophenyl)-5- [(Phenylamino)Carbonyl]-2H-Tetrazolium Hydroxide (XTT) Assay and a Modified NCCLS Method. Antimicrob. Agents Chemother.
49: 1364-1368
[Abstract]
[Full Text]
-
Ahmed, A. O. A., van de Sande, W. W. J., van Vianen, W., van Belkum, A., Fahal, A. H., Verbrugh, H. A., Bakker-Woudenberg, I. A. J. M.
(2004). In Vitro Susceptibilities of Madurella mycetomatis to Itraconazole and Amphotericin B Assessed by a Modified NCCLS Method and a Viability-Based 2,3-Bis(2-Methoxy-4-Nitro-5- Sulfophenyl)-5-[(Phenylamino)Carbonyl]-2H- Tetrazolium Hydroxide (XTT) Assay. Antimicrob. Agents Chemother.
48: 2742-2746
[Abstract]
[Full Text]
-
Ahmed, A. O. A., Desplaces, N., Leonard, P., Goldstein, F., De Hoog, S., Verbrugh, H., van Belkum, A.
(2003). Molecular Detection and Identification of Agents of Eumycetoma: Detailed Report of Two Cases. J. Clin. Microbiol.
41: 5813-5816
[Abstract]
[Full Text]
-
Ahmed, A., van de Sande, W., Verbrugh, H., Fahal, A., van Belkum, A.
(2003). Madurella mycetomatis Strains from Mycetoma Lesions in Sudanese Patients Are Clonal. J. Clin. Microbiol.
41: 4537-4541
[Abstract]
[Full Text]
-
Ahmed, A., Adelmann, D., Fahal, A., Verbrugh, H., van Belkum, A., de Hoog, S.
(2002). Environmental Occurrence of Madurella mycetomatis, the Major Agent of Human Eumycetoma in Sudan. J. Clin. Microbiol.
40: 1031-1036
[Abstract]
[Full Text]